Acta Neuropathologica

, Volume 120, Issue 1, pp 67–74

Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord

  • Heiko Braak
  • Albert Ludolph
  • Dietmar R. Thal
  • Kelly Del Tredici
Original Paper

Abstract

Skein-like and spherical inclusions within the somatodendritic compartment of a few types of susceptible neurons in the human nervous system are the currently acknowledged pathological hallmarks of amyotrophic lateral sclerosis (ALS). These inclusions consist chiefly of an aggregated, phosphorylated, and ultimately ubiquitinated intranuclear protein, TDP-43. To investigate the development of these inclusions, a single neuronal type that is susceptible to the ALS-associated pathological process, i.e., the class of large multipolar somatomotor neurons in the lower brainstem and spinal cord, was studied in four cases of sporadic ALS and four age-matched controls using immunoreactions against phosphorylated TDP-43 (pTDP-43), p62, and ubiquitin. In these neurons, the protein TDP-43, after its displacement outside of the cell nucleus and abnormal phosphorylation, forms light microscopically visible dash-like aggregates which were dispersed throughout their entire somatodendritic domain and even extended into the proximal portions of the axon. Many motor neurons contained these lesions, which were not detectable with anti-TDP-43 and anti-p62. In an additional step, a small number of the neurons that contain the dash-like lesions displayed a clustering of the aggregated material, which forms thick net-like (potential precursors of the skein-like inclusions) and spherical inclusions. This material, in turn, was ubiquitinated and p62-immunopositive. Thus, dash-like pTDP-43 aggregates are regularly seen in motor neurons in ALS and may represent the initial cellular lesion in this disease. Because these aggregates were not stained with antibodies against p62 and non-phosphorylated TDP-43, it is possible that phosphorylation of TDP-43 is required for its aggregation in sporadic ALS.

Keywords

Amyotrophic lateral sclerosis Axonopathy Brainstem Somatomotor neurons Proteinopathy p62 Phosphorylated TDP-43 Spinal cord 

References

  1. 1.
    Arai T, Hasegawa M, Akiyama H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602–611CrossRefPubMedGoogle Scholar
  2. 2.
    Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87:554–567CrossRefPubMedGoogle Scholar
  3. 3.
    Braak E, Sandmann-Keil D, Rüb U et al (2001) Alpha-synuclein immunopositive Parkinson’s disease-related inclusion bodies in lower brainstem nuclei. Acta Neuropathol 101:195–201PubMedGoogle Scholar
  4. 4.
    Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259CrossRefPubMedGoogle Scholar
  5. 5.
    Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213–216CrossRefPubMedGoogle Scholar
  6. 6.
    Braak H, Del Tredici K (2009) Neuroanatomy and pathology of sporadic Parkinson’s disease. Adv Anat Embryol Cell Biol 201:1–119PubMedGoogle Scholar
  7. 7.
    Braak H, Del Tredici K, Rüb U (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–210CrossRefPubMedGoogle Scholar
  8. 8.
    Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res 318:121–134CrossRefPubMedGoogle Scholar
  9. 9.
    Brandmeir NJ, Geser F, Kwong LK et al (2008) Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 115:123–131CrossRefPubMedGoogle Scholar
  10. 10.
    Davidson Y, Kelley T, Mackenzie IR et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113:521–533CrossRefPubMedGoogle Scholar
  11. 11.
    Dickson DW, Josephs KA, Amador-Ortiz C (2007) TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 114:71–79CrossRefPubMedGoogle Scholar
  12. 12.
    Fujita Y, Mizuno Y, Takatama M, Okamoto K (2008) Anterior horn cells with abnormal TDP-43 immunoreactivities show fragmentation of the Golgi apparatus in ALS. J Neurol Sci 269:30–34CrossRefPubMedGoogle Scholar
  13. 13.
    Geser F, Brandmeir NJ, Kwong LK et al (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65:636–641CrossRefPubMedGoogle Scholar
  14. 14.
    Geser F, Martinez-Lage M, Kwong LK, Lee VM, Trojanowski JQ (2009) Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol 256:1205–1214CrossRefPubMedGoogle Scholar
  15. 15.
    Geser F, Martinez-Lage M, Robinson J et al (2009) Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 66:180–189CrossRefPubMedGoogle Scholar
  16. 16.
    Hasegawa M, Arai T, Nonaka T et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60–70CrossRefPubMedGoogle Scholar
  17. 17.
    Kato S, Shaw P, Wood-Allum C, Leigh PN, Shaw CE (2003) Amyotrophic lateral sclerosis. In: Dickson DW (ed) Neurodegeneration: the molecular pathology of dementia and movement disorders. ISN Neuropathologica Press, Basel, pp 350–371Google Scholar
  18. 18.
    Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241–1253PubMedGoogle Scholar
  19. 19.
    Leigh PN, Anderton BH, Dodson A et al (1988) Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett 93:197–203CrossRefPubMedGoogle Scholar
  20. 20.
    Lin WL, Dickson DW (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative disease. Acta Neuropathol 116:205–213CrossRefPubMedGoogle Scholar
  21. 21.
    Lowe J, Lennox G, Jefferson D et al (1988) A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett 94:203–210CrossRefPubMedGoogle Scholar
  22. 22.
    Mackenzie IR, Bigio EH, Ince PG et al (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427–434CrossRefPubMedGoogle Scholar
  23. 23.
    Mizuno Y, Amari M, Takatama M et al (2006) Immunoreactivities of p62, an ubiquitin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis. J Neurol Sci 249:13–18CrossRefPubMedGoogle Scholar
  24. 24.
    Mori F, Tanji K, Zhang HX et al (2008) Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 116:193–204CrossRefPubMedGoogle Scholar
  25. 25.
    Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133CrossRefPubMedGoogle Scholar
  26. 26.
    Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM (2007) TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol 64:1388–1394CrossRefPubMedGoogle Scholar
  27. 27.
    Neumann M, Kwong LK, Lee EB et al (2009) Phosphorylation of S409/410 of TDP is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117:137–149CrossRefPubMedGoogle Scholar
  28. 28.
    Piao YS, Wakabayashi K, Kakita A et al (2003) Neuropathology with clinical correlations of sporadic amyotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 13:10–22PubMedCrossRefGoogle Scholar
  29. 29.
    Tan CF, Eguchi H, Tagawa A et al (2007) TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 113:535–542CrossRefPubMedGoogle Scholar
  30. 30.
    Thal DR, Rüb U, Schultz C et al (2000) Sequence of Aβ protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 59:733–748PubMedGoogle Scholar
  31. 31.
    Thal DR, Rüb U, Orantes M, Braak H (2002) Phases of Abeta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800PubMedGoogle Scholar
  32. 32.
    Zatloukai K, Stumptner C, Fuchsbichler A et al (2002) p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160:255–263Google Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Heiko Braak
    • 1
  • Albert Ludolph
    • 1
  • Dietmar R. Thal
    • 1
  • Kelly Del Tredici
    • 1
  1. 1.Clinical Neuroanatomy, Department of Neurology, Center for Clinical ResearchUniversity of UlmUlmGermany

Personalised recommendations